Medical Trials Analysis (MTA) Group is a comprehensive CRO providing a full range of services for clinical trials, clinical research and medical education linked to clinical research. MTA's mission is to provide services aimed to FOCUS, harmonize the entire trial management process and to SPEED the INNOVATION in MEDICAL SCIENCE toward the delivery of any new therapeutic treatments and intervention that will improve patient quality of life. The key feature of MTA is the distinctly scientific matrix and its strong link with the academic and research environments. Beside feasibility studies, regulatory activities, management and monitoring services for clinical research, MTA provides methodological support to hospitals, universities and research centers for the preparation and finalization of clinical trial protocols. MTA is also actively involved in the educational field being involved in the Master Degree in School of Clinical Research and Epidemiology at the University of Ferrara and providing continuous education courses to public institutions and private companies. MTA Group includes two separate companies. One, MTA Swiss is located in Switzerland and is devoted to the coordination and management of international clinical research projects with an area of activity encompassing 30 countries worldwide. The other one, MTA Italy is located in Italy and is a fully accredited CRO according to the Italian local requirements (DM 15/11/2011) devoted to the conduction of clinical trials in Italy. MTA is a young and dynamic company strongly oriented on the innovative nature of the strategic and operational approaches applicable to the activities and the services provided. This is possible thanks to a highly qualified team with 70% of staff with a postgraduate qualification and constantly updated within their areas of activity through an annual very extended and customized training plan.